All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Top Biopharma Trends of 2021
    • Top Med-tech Trends of 2021
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 16, 2022
Home » Authors » Tiffany Turner

Tiffany Turner

Articles

ARTICLES

Middlebrook Gets $100M and a New Management Team

Nov. 1, 2011
By Tiffany Turner
No Comments
No Abstract
Read More

IDM Pleased with Data from Osteosarcoma Program

Nov. 1, 2011
By Tiffany Turner
No Comments
No Abstract
Read More

LigoCyte Sets Series C Terms: $28M for Vaccine Development

Nov. 1, 2011
By Tiffany Turner
No Comments
No Abstract
Read More

NewCo News: Cortria Aims to Capitalize on Dyslipidemia Market

July 21, 2008
By Tiffany Turner
No Comments

BioAlliance Stops Doxorubicin Trial After Pulmonary Reactions

July 17, 2008
By Tiffany Turner
No Comments

Avastin, Tarceva Sales Boost Genentech's Quarterly Earnings

July 16, 2008
By Tiffany Turner
No Comments

Neurogen Halts Dosing of Adipiplon in Insomnia

July 15, 2008
By Tiffany Turner
No Comments

Big Pharmas Team Up to Link Technology and Business Needs

July 11, 2008
By Tiffany Turner
No Comments

SGX Shares Soar on Merger Giving Lilly Technology Boost

July 10, 2008
By Tiffany Turner
No Comments

Seattle Genetics Nets $4M in Deal with Daiichi Sankyo

July 9, 2008
By Tiffany Turner
No Comments
View All Articles by Tiffany Turner

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 13, 2022.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for May 13.
  • Hearing ear icon

    Cochlear to acquire rival Oticon Medical for $121M

    BioWorld MedTech
    Cochlear Ltd. will acquire Danish hearing implant company Oticon Medical A/S for AU$170 million (US$121 million) after parent company the Demant Group said it...
  • Illustration of cancer cells and immunotherapy treatment

    Former Genentech execs launch new immunotherapy biotech LTZ Therapeutics

    BioWorld
    After raising $17 million in seed funding, immunotherapy-focused biotech company, LTZ Therapeutics Inc., is announcing plans for the fledgling company whose...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Archives
    • Today's news
    • Search BioWorld Science
    • About
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing